J. Vitti

Weight loss effect of liraglutide in real-life: the experience of a single Italian obesity center

G. Ceccarini, P. Fierabracci, F. Ferrari, 2020, Journal of Endocrinological Investigation.

LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

G. Ceccarini, P. Fierabracci, S. Magno, 2018, Lipids in health and disease.

Serum IGF-binding protein 2 (IGFBP-2) concentrations change early after gastric bypass bariatric surgery revealing a possible marker of leptin sensitivity in obese subjects

F. Santini, G. Ceccarini, M. Maffei, 2019, Endocrine.

Obesity is a Risk Factor for Erosive Gastroesophageal Reflux Disease: Prospective Case-Control Study

M. Anselmino, E. Savarino, F. Santini, 2014 .

Liver Enlargement Predicts Obstructive Sleep Apnea–Hypopnea Syndrome in Morbidly Obese Women

F. Santini, G. Ceccarini, G. Scartabelli, 2018, Front. Endocrinol..

LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

G. Ceccarini, P. Fierabracci, S. Magno, 2018, Lipids in health and disease.